GENSIA, NICHOLS NAME EXECUTIVESGensia Pharmaceuticals Inc. (NASDAQ:GNSA) of San Diego saidCarl F. Bobkoski has been hired as executive vice president,responsible for finance, business development, sales andmarketing and Gensia Europe Ltd. Bobkoski had been presidentand chief executive at GalenPharma Inc., a developer ofpharmaceuticals for neurological indications. Gensia focuses ondrugs for cardiovascular diseases.

Nichols Institute (AMEX:LAB) of San Juan Capistrano, Calif., anoperator of diagnostic testing services, has named Delbert A.Fisher president of its Nichols Institute Reference Laboratoriesunit. Fisher, professor emeritus at the UCLA School ofMedicine's department of pediatrics and medicine, replacesWayne C. Patterson, who joined the consulting firm of King,Chapman, Broussard and Gallagher in Denver. Nichols also hashired Michael G. Bissell, formerly director of clinical pathologyat City of Hope National Medical Center in Duarte, Calif., as vicepresident and medical director.

(c) 1997 American Health Consultants. All rights reserved.